Louise Ormond

The evolutionary history of human spindle genes includes back-and-forth gene flow with Neandertals

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Mechanisms of SARS-CoV-2 entry into cells

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status

COVID-19: A review of therapeutic strategies and vaccine candidates

COVID-19: A promising cure for the global panic

Dating genomic variants and shared ancestry in population-scale sequencing data

Temporal Detection and Phylogenetic Assessment of SARS-CoV-2 in Municipal Wastewater

Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections

SARS-CoV-2 variants, spike mutations and immune escape

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation

SARS-CoV-2 in wastewater: State of the knowledge and research needs

The mechanism of resistance to favipiravir in influenza

Proinflammatory Cytokines in the Olfactory Mucosa Result in COVID-19 Induced Anosmia

FATE OF MYCOBACTERIUM TUBERCULOSIS IN MOUSE TISSUES AS DETERMINED BY THE MICROBIAL ENUMERATION TECHNIQUE

The sterilizing value of rifampicin and pyrazinamide in experimental short course chemotherapy

The early bactericidal activity of drugs in patients with pulmonary tuberculosis.

Clinical and Toxicodynamic Evidence that High-Dose Pyrazinamide Is Not More Hepatotoxic than the Low Doses Currently Used

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

THE FATE OF MYCOBACTERIUM TUBERCULOSIS IN MOUSE TISSUES AS DETERMINED BY THE MICROBIAL ENUMERATION TECHNIQUE

The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution

Emergence of genomic diversity and recurrent mutations in SARS-CoV-2

The course of pulmonary tuberculosis during long-term single-drug (isoniazid) therapy.

Pyrazinamide-isoniazid in tuberculosis. I. Results in 58 patients with pulmonary lesions one year after the start of therapy.

Inferring the age of a fixed beneficial allele

The influence of pyrazinamide-isoniazid on M. tuberculosis in animals and man.

Pyrazinamide-isoniazid in tuberculosis.